Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-16 · accession 0001104659-22-119974 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-17 | 2022-11-16 | PTGX | Liu David Y | Chief R, D Strategy Off | M - OptEx | $2.31 | +100.5K | 80.9K | New | +$231.8K |
| DM | 2022-11-17 | 2022-11-16 | PTGX | Liu David Y | Chief R, D Strategy Off | M - OptEx | $0.00 | -100.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-16 | M | A | 35,656 | $1.16 | 132,259 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-16 | M | A | 5,999 | $1.89 | 96,603 | D | — | — | |
| 3 | Common | Common Stock | 2022-11-16 | M | A | 9,726 | $1.89 | 90,604 | D | — | — | |
| 4 | Common | Common Stock | 2022-11-16 | M | A | 35,331 | $4.21 | 167,590 | D | — | — | |
| 5 | Common | Common Stock | 2022-11-16 | M | A | 13,767 | $0.87 | 80,878 | D | — | — | (F1) Includes an aggregate of 573 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2022 and September 9, 2022. |
| 6 | Derivative | Stock Option (right to buy) | 2022-11-16 | M | D | 9,726 | $0.00 | 0 | D | $1.89 · — to 2024-10-22 | 9,726 Common Stock | (F2) The stock option is vested in full. |
| 7 | Derivative | Stock Option (right to buy) | 2022-11-16 | M | D | 13,767 | $0.00 | 0 | D | $0.87 · — to 2023-09-26 | 13,767 Common Stock | (F2) The stock option is vested in full. |
| 8 | Derivative | Stock Option (right to buy) | 2022-11-16 | M | D | 35,331 | $0.00 | 0 | D | $4.21 · — to 2026-04-29 | 35,331 Common Stock | (F2) The stock option is vested in full. |
| 9 | Derivative | Stock Option (right to buy) | 2022-11-16 | M | D | 35,656 | $0.00 | 0 | D | $1.16 · — to 2025-10-28 | 35,656 Common Stock | (F2) The stock option is vested in full. |
| 10 | Derivative | Stock Option (right to buy) | 2022-11-16 | M | D | 5,999 | $0.00 | 0 | D | $1.89 · — to 2025-03-26 | 5,999 Common Stock | (F2) The stock option is vested in full. |